Multiparametric assessment of sensorimotor abnormalities in vulnerable populations: A window of opportunity

This commentary suggests that neuroscience research on young healthy heavy cannabis users and patients with cannabis-induced psychosis using multimodal assessment of sensorimotor dysfunction (e.g. neuroimaging, clinical rating scales, and instrumental assessments) may help to identify both biological resistance and vulnerability without constraints and confounder factors imposed by antipsychotic treatment or disease chronicity.

Automated summary

This commentary suggests that conducting neuroscience research on young healthy heavy cannabis users and patients with cannabis-induced psychosis using multimodal assessment of sensorimotor dysfunction can help identify biological resistance and vulnerability without the constraints and confounding factors imposed by antipsychotic treatment or disease chronicity.